539470 — Shree Ganesh Bio-Tech (India) Income Statement
0.000.00%
Last trade - 00:00- IN₹370.72m
- IN₹370.62m
- IN₹202.78m
- 70
- 59
- 43
- 62
Annual income statement for Shree Ganesh Bio-Tech (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 24.7 | 172 | 726 | 625 | 203 |
| Cost of Revenue | |||||
| Gross Profit | 8.98 | 8.84 | 38.1 | 28.3 | 2.46 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22.4 | 168 | 692 | 603 | 205 |
| Operating Profit | 2.36 | 4.28 | 34.5 | 21.5 | -2.01 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.36 | 4.28 | 35 | 27.1 | 8.55 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.36 | 3.17 | 25.3 | 20.4 | 6.21 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.36 | 3.17 | 25.3 | 20.4 | 6.21 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.36 | 3.17 | 25.3 | 20.4 | 6.21 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.006 | 0.014 | 0.066 | 0.051 | 0.016 |